Monark Biocare offers pcd pharma franchise in India on a monopoly basis. We are also offering a Pharmaceutical Products range on PCD Based B
Why Indian Pharmaceuticals Dominate the Export Market?
India has emerged as a dominant force in the global pharmaceutical export market, particularly as the largest supplier of generic medicines, contributing nearly 20% of global export volumes. Several key factors contribute to this success.
Affordable Manufacturing: A major driver behind Indiaโs leadership is its ability to manufacture high-quality medicines at significantly lower costs than many other countries. With a well-established manufacturing infrastructure and numerous FDA-approved facilities, India provides cost-effective solutions to the worldโs healthcare demands.
Talented Workforce and Innovation: The country boasts a large pool of skilled scientists and researchers, supported by an extensive network of affordable technical and educational institutions. This talent base drives ongoing innovation in drug development and enables the production of complex pharmaceutical products.
Adherence to Global Standards: Indian pharmaceutical firms are recognized for maintaining strict compliance with international regulatory standards. Many hold certifications from major global agencies like the US FDA, EMA, and WHO, earning the trust of markets worldwide.
Widening International Presence: Beyond generics, India is also making strides in specialized areas such as biosimilars and vaccines. Its increasing global presence reflects the countryโs crucial role in delivering accessible healthcare across the world.
In summary, Indiaโs pharmaceutical export success is rooted in its combination of low production costs, technical expertise, innovation, and strong regulatory practicesโpositioning it as a key player in global healthcare.
